ArticleFrontiers in immunology2023

TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.

Huadong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.